Neutralization of MERS coronavirus through a scalable nanoparticle vaccine

Abstract MERS-CoV continues to cause human outbreaks, so far in 27 countries worldwide following the first registered epidemic in Saudi Arabia in 2012. In this study, we produced a nanovaccine based on virus-like particles (VLPs). VLPs are safe vaccine platforms as they lack any replication-competen...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mona O. Mohsen, Dominik Rothen, Ina Balke, Byron Martina, Vilija Zeltina, Varghese Inchakalody, Zahra Gharailoo, Gheyath Nasrallah, Said Dermime, Kaspars Tars, Monique Vogel, Andris Zeltins, Martin F. Bachmann
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Acceso en línea:https://doaj.org/article/75e90d2e660e4495962a2ced6e6426ae
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!